chlorin e4: RN given for (2S-trans)-isomer; structure in first source [MeSH]
| ID Source | ID |
|---|---|
| PubMed CID | 25060996 |
| SCHEMBL ID | 14039063 |
| MeSH ID | M0451444 |
| Synonym |
|---|
| 21h,23h-porphine-7-propanoic acid, 3-carboxy-13-ethenyl-18-ethyl-7,8-dihydro-2,5,8,12,17-pentamethyl-, (7s,8s)- |
| chlorin e4 |
| 550-52-7 |
| SCHEMBL14039063 |
| 21h,23h-porphine-7-propanoic acid,3-carboxy-13-ethenyl-18-ethyl-7,8-dihydro-2,5,8,12,17-pentamethyl-,(7s,8s)- |
| 21h,23h-porphine-7-propanoicacid,3-carboxy-13-ethenyl-18-ethyl-7,8-dihydro-2,5,8,12,17-pentamethyl-,(7s,8s)- |
| (17s,18s)-18-(2-carboxyethyl)-12-ethenyl-7-ethyl-3,8,13,17,20-pentamethyl-17,18,22,23-tetrahydroporphyrin-2-carboxylic acid |
| CS-0185979 |
| HY-W127809 |
| (17s,18s)-18-(2-carboxyethyl)-12-ethenyl-7-ethyl-3,8,13,17,20-pentamethyl-17,18-dihydroporphyrin-2-carboxylic acid |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| indomethacin | aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole | analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic | 2001 | 2001 | 23.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | |
| serine | L-alpha-amino acid; proteinogenic amino acid; serine family amino acid; serine zwitterion; serine | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 2019 | 2019 | 5.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
| n-vinyl-2-pyrrolidinone | pyrrolidin-2-ones | 2019 | 2019 | 5.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | ||
| transferrin | 2019 | 2019 | 5.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |||
| phytochlorin | 2008 | 2019 | 10.5 | high | 0 | 0 | 0 | 1 | 1 | 0 | |||
| chlorin p6 | 2008 | 2008 | 16.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | |||
| folic acid | folic acids; N-acyl-amino acid | human metabolite; mouse metabolite; nutrient | 2014 | 2014 | 10.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acute Liver Injury, Drug-Induced | 0 | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 | |
| Benign Neoplasms | 0 | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Cancer of Liver | 0 | 2008 | 2018 | 11.0 | medium | 0 | 0 | 0 | 1 | 1 | 0 | |
| Cancer of Lung | 0 | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Carbon Tetrachloride Poisoning | 0 | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 | |
| Carcinoma, Hepatocellular | 0 | 2008 | 2018 | 11.0 | medium | 0 | 0 | 0 | 1 | 1 | 0 | |
| Chemical and Drug Induced Liver Injury | 0 | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 | |
| Gastric Ulcer | 0 | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 | |
| Hepatocellular Carcinoma | 0 | 2008 | 2018 | 11.0 | medium | 0 | 0 | 0 | 1 | 1 | 0 | |
| Liver Neoplasms | 0 | 2008 | 2018 | 11.0 | medium | 0 | 0 | 0 | 1 | 1 | 0 | |
| Lung Neoplasms | 0 | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Neoplasms | 0 | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Stomach Ulcer | 0 | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |